The Pivotal Clinical Trial for its OncoSil™ localised radiation therapy for the treatment of pancreatic cancer will be supported by OncoSil Medical’s cash and deposits of $7 million at financial year end. The trial has already received Ethics Approval for its Australian sites and validated its manufacturing process.
News: OncoSil Medical funded to progress pancreatic cancer device
Add to My Watchlist
What is My Watchlist?